Atlas Trials

Lipid Metabolism, Inborn Errors

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Lipid Metabolism, Inborn Errors

RecordFirmDate
Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. (NCT05425745)NewAmsterdam Pharma2022-07-25
Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases (NCT02707211)Universitaire Ziekenhuizen KU Leuven2016-06-01
Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy (NCT02635269)Rigshospitalet, Denmark2016-01-01
Mendelian Reverse Cholesterol Transport Study (NCT01782027)University of Pennsylvania2012-10-01
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia (NCT00694109)Kastle Therapeutics, LLC2008-04-01
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia (NCT00607373)Kastle Therapeutics, LLC2007-07-01
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia (NCT00477594)Kastle Therapeutics, LLC2007-05-01
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration (NCT00362180)Kastle Therapeutics, LLC2006-07-01
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency (NCT00260299)Oregon Health and Science University2005-02-01
An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED) (NCT00092898)Organon and Co2004-10-01
Sitosterolemia Extension Study (0653-003)(COMPLETED) (NCT00092807)Organon and Co2001-02-12
Sitosterolemia Extension Study (0653-004)(COMPLETED) (NCT00092820)Organon and Co2001-02-12
Genetic Study of Sitosterolemia (NCT00004481)National Center for Research Resources (NCRR)1999-11-01

Track Lipid Metabolism, Inborn Errors automatically

Every clearance here is in the API, with alerts when new ones post.